Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis

por Reynoso-Moreno, Ines, Tietz, Silvia, Vallini, Erika, Engelhardt, Britta, Gertsch, Jürg, Chicca, Andrea
Publicado 2021

The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors

por Reynoso-Moreno, Inés, Chicca, Andrea, Flores-Soto, Mario E., Viveros-Paredes, Juan M., Gertsch, Jürg
Publicado 2018

The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer

por Saliakoura, Maria, Reynoso-Moreno, Inés, Pozzato, Chiara, Rossi Sebastiano, Matteo, Galié, Mirco, Gertsch, Jürg, Konstantinidou, Georgia
Publicado 2020